Related references
Note: Only part of the references are listed.Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells
Abhijit Sarkar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
2-(3′,4′-Dimethoxybenzylidene)tetralone induces anti-breast cancer activity through microtubule stabilization and activation of reactive oxygen species
Yashveer Gautam et al.
RSC ADVANCES (2016)
Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance
Roohi Gupta et al.
JOURNAL OF CONTROLLED RELEASE (2015)
D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells
Christiana M. Neophytou et al.
BIOCHEMICAL PHARMACOLOGY (2014)
A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer
Huihui Bu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Vitamin E-based nanomedicines for anti-cancer drug delivery
Nicolas Duhem et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response
Vivek K. Pawar et al.
JOURNAL OF CONTROLLED RELEASE (2014)
How Taxol/paclitaxel kills cancer cells
Beth A. Weaver
MOLECULAR BIOLOGY OF THE CELL (2014)
Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1
R. Neslihan Gursoy et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2014)
Development and characterization of cellulose-polymethacrylate mucoadhesive film for buccal delivery of carvedilol
Jaya Gopal Meher et al.
CARBOHYDRATE POLYMERS (2013)
The applications of Vitamin E TPGS in drug delivery
Yuanyuan Guo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Effect of chronic administration of tamoxifen and/or estradiol on feeding behavior, palatable food and metabolic parameters in ovariectomized rats
Carine Lampert et al.
PHYSIOLOGY & BEHAVIOR (2013)
Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer
Jianan Shen et al.
BIOMATERIALS (2012)
Vitamin E TPGS as a molecular biomaterial for drug delivery
Zhiping Zhang et al.
BIOMATERIALS (2012)
Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies
Yi Zhao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Multi-functional nanocarriers to overcome tumor drug resistance
Lara S. Jabr-Milane et al.
CANCER TREATMENT REVIEWS (2008)
A rat mammary gland cancer cell with stem cell properties of self-renewal and multi-lineage differentiation
Cinzia Cocola et al.
CYTOTECHNOLOGY (2008)
Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS:: Influence on ATPase activity and membrane fluidity
Eva-Maria Collnot et al.
MOLECULAR PHARMACEUTICS (2007)
Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles
SC Kim et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®)
L Mu et al.
JOURNAL OF CONTROLLED RELEASE (2002)
The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients
MM Malingré et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
